[1]CurrentPatentAssignee:NNAJINGHAOLVTECH-CN109020912,2018,A
[1]CurrentPatentAssignee:NNAJINGHAOLVTECH-CN109020912,2018,A
[1]CurrentPatentAssignee:NNAJINGHAOLVTECH-CN109020912,2018,A
[1]Patent:CN109020912,2018,A
[1]CurrentPatentAssignee:NNAJINGHAOLVTECH-CN109020912,2018,A
Title: Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis.
Journal: Arthritis and rheumatism 20120501
Title: Metabolism of the c-Fos/activator protein-1 inhibitor T-5224 by multiple human UDP-glucuronosyltransferase isoforms.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20110501
Title: Makino H, et al. A selective inhibition of c-Fos/activator protein-1 as a potential therapeutic target for intervertebraldisc degeneration and associated pain. Sci Rep. 2017 Dec 5;7(1):16983.
Title: Aikawa Y, et al. Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1. Nat Biotechnol. 2008 Jul;26(7):817-23.
Title: Kamide D, et al. Selective activator protein-1 inhibitor T-5224 prevents lymph node metastasis in an oral cancer model. Cancer Sci.?2016 May;107(5):666-73.
Title: Izuta S, et al. T-5224, a selective inhibitor of c-Fos/activator protein-1, attenuates lipopolysaccharide-induced liver injury in mice. Biotechnol Lett. 2012 Dec;34(12):2175-82.
Title: Uchihashi S, et al. Metabolism of the c-Fos/activator protein-1 inhibitor T-5224 by multiple human UDP-glucuronosyltransferase isoforms. Drug Metab Dispos. 2011 May;39(5):803-13.
Title: Miyazaki H, et al. The effects of a selective inhibitor of c-Fos/activator protein-1 on endotoxin-induced acute kidney injury in mice. BMC Nephrol. 2012 Nov 23;13:153.
